packageIcotinib

icotinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Icotinib is an EGFR tyrosine kinase inhibitor investigated for treating non-small-cell lung cancer. It is considered investigational and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q16868421 and the WHO ATC classification; not checked by a person.

name:icotinib
ATC codes:L01EB08
DrugBank:DB11737
PubChem CID:22024915
Wikidata:Q16868421
formula:C22H21N3O4
molar mass:391.427 g/mol (PubChem CID 22024915)
logP:3.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown